Acumen Pharmaceuticals, Inc.

NasdaqGS:ABOS 주식 보고서

시가총액: US$170.9m

Acumen Pharmaceuticals 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

내부자 거래량

내부자 구매: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


소유권 분석

ABOS 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업142,8950.238%
일반 대중2,993,1204.98%
개인 내부자9,169,66515.3%
VC/PE 기업18,349,13830.5%
교육기관29,424,96049%

주식의 희석: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.8%.


최대 주주

상위 25 주주가 회사의 88.29%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
24.9%
RA Capital Management, L.P.
14,932,063US$42.5m0%0.48%
5.74%
Robert Hardie
3,451,152US$9.8m0%데이터 없음
5.69%
Sands Capital Ventures, LLC
3,417,075US$9.7m0%2.38%
5.61%
Franklin Resources, Inc.
3,367,618US$9.6m0%데이터 없음
4.24%
Paul Manning
2,547,143US$7.2m0%데이터 없음
4.22%
James Murray
2,538,162US$7.2m0%데이터 없음
3.83%
Rock Springs Capital Management LP
2,300,059US$6.5m0%0.2%
3.59%
BlackRock, Inc.
2,158,661US$6.1m1,040%데이터 없음
3.37%
FMR LLC
2,022,103US$5.8m-3.2%데이터 없음
3.25%
Millennium Management LLC
1,954,085US$5.6m-25.7%데이터 없음
3.16%
The Vanguard Group, Inc.
1,896,949US$5.4m13.9%데이터 없음
2.87%
H7 Holdings, LLC
1,725,576US$4.9m0%100.0%
2.87%
Level One Partners LLC
1,725,576US$4.9m0%98.31%
2.71%
Knollwood Investment Advisory, LLC
1,628,510US$4.6m0%0.51%
1.96%
Laurion Capital Management LP
1,178,338US$3.4m-37.8%0.11%
1.74%
T. Rowe Price Group, Inc.
1,046,364US$3.0m-4.73%데이터 없음
1.56%
Alyeska Investment Group, L.P.
939,603US$2.7m0%0.01%
1.35%
Geode Capital Management, LLC
812,133US$2.3m185%데이터 없음
1.12%
Hudson Bay Capital Management LP
670,000US$1.9m19.6%0.02%
1.1%
Tiger Lily Capital
657,985US$1.9m0%데이터 없음
0.8%
Pathstone Family Office, LLC
480,223US$1.4m0.01%0.01%
0.73%
State Street Global Advisors, Inc.
436,565US$1.2m434%데이터 없음
0.71%
Jane Street Group, LLC, Asset Management Arm
427,689US$1.2m-28.8%데이터 없음
0.65%
Two Sigma Advisers, LP
392,100US$1.1m80.7%데이터 없음
0.56%
Renaissance Technologies LLC
338,100US$961.9k0%데이터 없음